Showing results (451-460 of 812) with videos related to
Sort By:
Pageof 82
Immunobiology|June 1, 1990
In vivo administration of cytokine in allogeneic bone marrow chimerasM Imamura, H Fujimoto, S Hashino, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Expression of the Na+/Ca2+ exchanger emerges in hepatic stellate cells after activation in association with liver fibrosisT Nakamura, S Arii, K Monden, et al.Anticancer Research|January 11, 2000
c-erbB-2, p53 protein expression and steroid hormone receptors in breast carcinomas: an immunohistochemical studyT Yokota, M Imamura, S Teshima, et al.Nihon Jibiinkoka Gakkai Kaiho|December 1, 1993
[Further study of Schellong testing in 152 young females]I Nozawa, K Hisamatsu, S Shimomura, et al.Hepatology (Baltimore, Md.)|June 1, 1996
Chemical mediators released by primary-cultured human hepatic macrophages in patients with and without cirrhosis: a study in tumor-bearing patientsN Funaki, S Arii, K Monden, et al.Diabetes|August 1, 1996
Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivoT Utsugi, J W Yoon, B J Park, et al.Immunobiology|February 1, 1988
Non-specific suppressor cells in murine bone marrow chimeras: their possible role in GVHD-associated immunodeficiencyM Imamura, H Fujimoto, T Fukuhara, et al.International Journal of Cancer|December 18, 2001
Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivoA Itami, G Watanabe, Y Shimada, et al.Cancer|March 30, 2000
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoproteinK Hamamura, Y Shiratori, S Shiina, et al.Cancer Journal (Sudbury, Mass.)|April 28, 2001
Progression of esophageal carcinoma by loss of EGF-STAT1 pathwayG Watanabe, J Kaganoi, M Imamura, et al.Pageof 82